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ABSTRACT: Despite evidence that low-carbohydrate diets (LCD) can improve metabolic syndrome
(MetS) characteristics and risk for cardiovascular disease, concerns remain regarding the potential
deleterious effects of higher fat intake. If higher fat intake (in the context of lower carbohydrate intake) is
accompanied by higher fat oxidation, there would likely be more efficient fat loss and improved health
parameters. Our aim was to examine how diets spanning a broad range of carbohydrate levels ranging
from very low (<50 g/day) to current dietary guidelines (~350 g/day) affect substrate oxidation patterns
and changes in body composition within the same person while keeping caloric and protein intake
constant. After an initial 3-wk run-in LCD, 16 adults with MetS (age 44.9 ± 9.9 yr, BMI 37.9 ± 6.3
kg/m2) were fed six sequential moderately hypocaloric 3-wk diets that progressively increased
carbohydrate (CHO) (from 47 to 344 g/day) with concomitant decreases in total fat. Body composition
was determined by dual-energy X-ray absorptiometry (DXA) and respiratory quotient (RQ), fat oxidation,
and resting energy expenditure (REE) were determined by indirect calorimetry after each diet phase.
Subjects lost significantly more fat mass (-2.32±1.53 kg) on the free-living LCD phase, but overall fat
mass loss was variable between subjects and on average less than expected from the calculated caloric
deficit (-8.3±4.5 vs 12.74±15.81 kg, respectively). There was a significant decrease in REE, but no
significant change in relative REE (kcals/kg/day). Fat oxidation rates significantly increased when
consuming diets with 7% CHO, but decreased to below baseline by the highest CHO phase. RQ
decreased on the LCD (0.75±0.04), and increased linearly as CHO increased, up to 0.84 ±0.05. Body
mass was significantly correlated with CHO consumption (r=0.49), insulin (r=0.34), fat consumption (r=0.49) and ketones (r=0.46). These findings suggest that it is difficult to estimate weight loss within an
individual, even with a constant caloric deficit, since individuals vary in their substrate oxidation response
to reintroduction of dietary carbohydrate. Those who can maintain a higher fat oxidation to a greater
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extent as carbohydrates are increased (and fat decreased) may possess an enhanced ability for fat loss on
higher carbohydrate diets.

ii

Effects of Incremental Dietary Macronutrient Changes on Fat Oxidation
and Body Composition

Laura Kunces

M.S., University of Connecticut, 2012
M.S., University of Memphis, 2009
B.S., University of Connecticut, 2008

A Dissertation
Submitted in Partial Fulfillment of the
Requirements for the Degree of Doctor of Philosophy
at the
University of Connecticut
2014

APPROVAL PAGE
Doctor of Philosophy

Effects of Incremental Dietary Macronutrient Changes on Fat Oxidation
and Body Composition
Presented by
Laura Kunces, M.S., M.S., R.D.

Major Advisor ___________________________________________________________
Jeff S. Volek, Ph.D., R.D.

Associate Advisor ________________________________________________________
Carl M. Maresh, Ph.D.

Associate Advisor ________________________________________________________
William J. Kraemer, Ph.D.

Associate Advisor ________________________________________________________
Maria Luz Fernandez, Ph.D.

University of Connecticut
2014

ii

Acknowledgements
I cannot put into words how thankful and fortunate I am to be in the UConn Kinesiology
Department over the last 4.5 years.
Thank you to my major advisor, Dr. Volek. I want to thank you for believing in me over the last
4.5 years. You have opened my eyes to the wonderful world of nutrition, outside of being a
close-minded dietitian, and I am appreciative of every second we get to spend talking science.
You are seriously one of the smartest people I have ever met and I am so proud to be one of your
students. Words cannot express my appreciation for you and how you have treated me like a
member of your family. Thank you for an amazing graduate school experience!!
Thank you, Dr. Fernandez. If it wasn't for you back in November of 2009, I would not be here in
the Department of Kinesiology. I want to say thank you for being such a positive female
research role model, being so supportive of the work of Dr. Volek, and all of your help over the
past few years. I feel lucky to say I have worked with you!
Thank you, Dr. Kraemer. Thank you for all of the opportunities you provided to us studentsfrom reviewer opportunities, to experience with countless studies, to really good stories about
celebrities and professional athletes you get to rub elbows with. Your humor and loving
personality is always a welcome and I really appreciate all of the help you have given me over
the years.
Thank you, Dr. Maresh. Thank you for being such a down to earth guy. You are one of the best
mentors to each and every student in this department. Everyone really looks up to you and I
know we all hope to be as well balanced as you are- from work, to research, to family. I really
want to thank you for all the support you have given me over the years. We will all miss you and
best of luck on your next adventures.
Additionally, thank you to Dr. Armstrong for including me in his research studies and
celebration happy hours! Your classes at UConn were some of the most interesting because you
are so passionate about the topics and about teaching, thank you!
Thank you, Dr. Casa. Thank you for including me in your studies and extracurricular activities!
I have learned a lot from you and your students! Your positive attitude is contagious!
Thank you, Dr. Lee. Thank you for all of the help you have given me over the past few years,
including helping me get a job! Your positive attitude and genuine care for students is obvious,
and appreciated by everyone! You are going to be very successful and I am happy to say I have
worked with you.
To the Volek group (Dan, Cathy and Brittanie)- thank you for always being team players! You
guys are the best group anyone could ask for and I am happy and proud to be part of the Volek
Team with you!
Thank you to some of the best friends I have made in the HPL over the years- Amy, Colleen,
Jenna, and Ashley! Wouldn't have been able to do it without you!
Finally, thank you to my loving fiancé Ernesto, and my parents and brother for the emotional and
financial support! I love you all!

iii

Table of Contents
Abstract .......................................................................................................................................................... i
Review of Literature ..................................................................................................................................... 1
Metabolic Syndrome ........................................................................................................................ 1
Table 1 ............................................................................................................................................. 3
Current Dietary Recommendations.................................................................................................. 3
Low-Carbohydrate Diets….............................................................................................................. 4
Ketone Physiology and Regulation .................................................................................................. 5
Body Composition Changes ............................................................................................................ 6
Insulin Sensitivity .......................................................................................................................... 12
Theoretical Low-Carbohydrate Ideas: Nonequilibrium Thermodynamics .................................... 12
Requirements of Metabolism ......................................................................................................... 14
Gluconeogenesis-stimulated Protein Turnover .............................................................................. 15
Behavioral Effects.......................................................................................................................... 15
Low-Carbohydrate Diet Research Limitations .............................................................................. 17
Introduction ................................................................................................................................................. 19
Methods ...................................................................................................................................................... 23
Screening ....................................................................................................................................... 23
Study Design .................................................................................................................................. 24
Figure 1. ......................................................................................................................................... 24
Testing ........................................................................................................................................... 24
Blood Draws and Analysis............................................................................................................. 25
Dietary Intervention ....................................................................................................................... 26
Statistical Analysis ......................................................................................................................... 28
Results ......................................................................................................................................................... 29
Subjects .......................................................................................................................................... 29
Table 2 ........................................................................................................................................... 29
Table 3 ........................................................................................................................................... 30
Dietary Intake ................................................................................................................................ 30
Weight Loss, Resting Energy Expenditure .................................................................................... 31
Figure 2 .......................................................................................................................................... 31
Figure 3 .......................................................................................................................................... 32
Figure 4 .......................................................................................................................................... 33
Figure 5 .......................................................................................................................................... 34
Respiratory Quotient ...................................................................................................................... 34
Figure 6 .......................................................................................................................................... 35
Figure 7 .......................................................................................................................................... 36
Fasted Fat Oxidation ...................................................................................................................... 36
Figure 8 .......................................................................................................................................... 37
Figure 9 .......................................................................................................................................... 38
Figure 10 ........................................................................................................................................ 38
Insulin, Ketones, HOMA ............................................................................................................... 39
Figure 11 ........................................................................................................................................ 39
Dietary Correlations ....................................................................................................................... 40
Discussion ................................................................................................................................................... 41
Table 4 ........................................................................................................................................... 47
Table 5 ........................................................................................................................................... 48
Table 6 ........................................................................................................................................... 49
References ................................................................................................................................................... 50

iv

REVIEW OF LITERATURE
“Eat less, exercise more” is the advice from many public health experts to obese people.
Clearly the failure to curtail the burgeoning obesity epidemic suggests this paradigm may be
flawed. An alternative perspective is that obesity is due to excess accumulation of energy in
adipose tissue, and that factors controlling flux of energy in and out of adipocytes is fundamental
in understanding obesity. This view emphasizes the importance of macronutrient composition
on fat balance.
The simple law of thermodynamics in the form of the equation ‘calories in minus calories
out’ equaling weight loss has been challenged with recent research regarding the efficacy of
hypocaloric diets. As the obesity epidemic around the world grows, a dietary strategy to reduce
the incidence of metabolic syndrome continues on the research forefront and macronutrient
composition of diets has been a point of contention. Research continues to test low carbohydrate
diets (LCDs) and their ability to trump the recommended low calorie or low-fat (LF) diet for
weight loss and body composition improvements in those who may benefit the most.
Metabolic Syndrome
Obesity is one of the most common diseases among adults in the world. More than 35%
of American adults (defined as BMI >30 kg/m2) and 17% of children are obese (defined as >95th
percentile for BMI), with numbers on the rise each year (Ogden, Carroll, Kit, & Flegal, 2014).
Obesity is known to upset lipid and glucose metabolism and disrupt cellular metabolism by
releasing numerous cytokines contributing to comorbidities (Redinger, 2007). Metabolic
syndrome (MetS) is a diagnosis representing a multitude of complex pathways emergent from
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the growing obesity epidemic. It is estimated more than 34% of the United Stated has MetS
(Mozumdar & Liguori, 2011), and although the risk factors are seriously significant to your
health, dietary modifications (Andersen & Fernandez, 2013) and lifestyle changes can help
reduce body weight and manage the dyslipidemias associated. MetS is a combination of
metabolic abnormalities that increase the risk for type 2 diabetes mellitus (T2DM) and coronary
heart disease (CHD) exponentially (Meigs et al., 2007).

Insulin resistance is strongly influenced by obesity through elevated plasma fatty acid
levels (Coppack, Jensen, & Miles, 1994). The excessive storage of fat that defines obesity,
eventually leads to excessive stored and circulating fatty acids, creating oxidant stress to each
cell’s mitochondria and endoplasmic reticulum. The stored and circulating fatty acids inhibit
lipogenesis, preventing adequate clearance of serum triacylglycerols, contributing to
hypertriglyceridemia. The release of fatty acids by endothelial lipoprotein lipase from serum
triglycerides with elevated β-lipoproteins causes lipotoxicity and insulin receptor dysfunction.
This condition is often followed by hyperglycemia, and compensated with gluconeogenesis.
Increased circulating fatty acids are able to stimulate insulin secretion, however, fatty acidinduced insulin secretion is strongly dependent on carbohydrate levels of the diet (Stein et al.,
1996). Hyperglycemia is further attenuated when fatty acids decrease the utilization of insulinstimulated muscle glucose (Boden, Chen, Ruiz, White, & Rossetti, 1994). Lipotoxicity from the
elevated circulating free fatty acids also decreases pancreatic β-cell ability to produce insulin
(Unger, 1995), resulting in insulin resistance.
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MetS is classified as having at least three of the parameters in Table 1 (Third Report of
the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, 2002).
In addition, because of the associated increased risk for CHD and T2DM, MetS is often
combined with imbalances of inflammation markers and hormones. Although there are various
similar definitions of MetS defined by different health organizations, most can agree that diet
and lifestyle should be addressed as the first option for prevention or treatment.

Table 1. NCEP defined metabolic syndrome diagnosis characteristics.
Metabolic Characteristic
Men
Women
Waist circumference
>102 cm
>88 cm
High Density Lipoprotein (HDL) Cholesterol
<40 mg/dL <50 mg/dL
Fasting serum blood glucose
>100 mg/dL
Blood pressure
>130/85 mmHg*
Plasma triglycerides
>150 mg/dL
* or on blood pressure medications

Current Dietary Recommendations
Dietary fat and saturated fat have been the focus of nutritional recommendations for over
three decades. The latest guidelines issued by the Dietary Guidelines Advisory Committee
(DGAC) encourages Americans to consume less than 35% of their calories from fat, and to keep
saturated fat consumption to less than 7% (Lichtenstein et al., 2006). Protein recommendations
are set at a modest 0.8 g/kg body weight (15-20% of calories) and carbohydrates are to comprise
of the remaining calories (55-65%). According to dietary trends, there has been a decrease in fat
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and saturated fat consumption, but Americans have seemed to replace the fat they previously
consumed with high carbohydrate options (Trends in intake of energy and macronutrients-United States, 1971-2000, 2004) and the incidence of obesity and MetS continues to rise.

Low-Carbohydrate Diets
The mainstream use of LCDs as an obesity treatment began around 1960s, often
eliminating or reducing the numerous pharmaceutical prescriptions related to physical and
clinical unhealthy diagnoses. It is challenging to associate metabolic responses and clinical
outcomes to one nutrient, but carbohydrates have a complex link to plasma glucose and insulin,
and cellular function. With lower glucose availability, changes in insulin and glucagon
concentrations will shift the body away from storing fat, and start efficiently oxidizing fat.
LCDs need to be operationally defined, but there is a threshold effect seen around 20-50g/day in
clinical research where the body starts to produce ketones. Nutritional ketosis is reached when
systemic ketone blood levels are maintained between 0.5 mM and ~3.0 mM. Metabolic changes
and benefits are seen beyond this low threshold (Westman et al., 2007). Similar to many
metabolic changes, this threshold is variable for individuals and is dependent on their level of
carbohydrate tolerance.

A LCD would include the following foods: meat, eggs, fish, butter, and heavy cream,
moderate amounts of cheeses, low-carbohydrate vegetables, and salad dressings, and small
amounts of nuts and seeds. The diet restricts fruit and juices, breads, grains, pasta, cereal,
starchy vegetables, high-carbohydrate desserts, and most dairy products. It is a common
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misconception that a LCD increases protein consumption; contrarily, protein intake is set at
normal recommendations (15-25% of total calories). Recommended carbohydrate amount is
variable depending on the individuals’ tolerance and insulin sensitivity, but this diet is often
referred to as less than 50-150 grams of carbohydrates per day (Westman, et al., 2007) or about
10-25% of dietary caloric intake. To be in nutritional ketosis and producing ketones,
carbohydrate intake would likely need to be narrower (<10%), often referred to as a very-lowcarbohydrate ketogenic diet (VLCKD). Dietary fat would comprise the rest of dietary calories
(60-80% of calories). Micronutrients of sodium, potassium, and calcium should be monitored
and supplemented, as necessary. There are very few studies to date that report appropriate length
to be on a VLCKD to see optimal benefits from producing ketones, but the research concludes it
is clearly longer than one week and more likely around 3-4 weeks. The adaption process is not
dependent on weight, athleticism, or gender per research done to date (Phinney, 2004).

Ketone Physiology and Regulation
The rationale for reducing dietary carbohydrates derives from basic mechanisms: dietary
carbohydrates are not essential and therefore are not needed to provide energy. Fatty acids
provided from dietary fat or adipose stores, and ketone bodies created from dietary fat and
adipose stores are all converted to be the main fuel sources in a LCD. Skeletal muscle can
efficiency survive on burning fats as their main fuel source, however, fatty acids are unable to
cross the blood brain barrier to be utilized by the central nervous system. Even though the brain
would preferentially burn glucose, it easily adapts to using ketones just as efficiently. Ketones
are produced in three forms: acetoacetate, B-hydroxybuterate, and acetone. The brain can use
acetoacetate or B-hydroxybuterate, while acetone is excreted via the lungs as waste. The rate of
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ketogenesis is regulated by hormone sensitive lipase (HSL). While very little to no dietary
carbohydrates are consumed, glucose levels can be sustained by increases in pancreatic glucagon
secretion, which phosphorylates adipose HSL, resulting in hepatic ketogenesis liberating fatty
acids from adipose tissue. Additionally, gluconeogenesis can occur using dietary protein and fat.
Gluconeogenesis depletes the Kreb’s cycle intermediates and increases acetyl-CoA, the substrate
needed to initiate aerobic oxidation. Elevated insulin levels inhibit ketogenesis through
dephosphorylation and inactivation of adipose HSL. The elevated levels of Malonyl-CoA
produced from fatty acid synthesis are a negative feedback inhibitor, preventing fatty acids
entrance to the mitochondria. This ultimately inhibits ketone production. The differences
between a LCD and a starvation or low-calorie diet is the ability of the body to maintain serum
glucose levels and spare the breakdown of endogenous protein (J. S. Volek & Westman, 2002)
while consuming a LCD.

Body Composition Changes
Health benefits resulting from weight loss are linked to body fat loss and attenuation of
muscle mass loss, however, diet regimens that focus on decreasing weight tend to decrease both
lean and fat mass. This undesirable result is seen in about 25% of studies that focus on weight
loss outcomes through LF diets (Kraemer et al., 1999; Layman et al., 2005) despite similar
hypocaloric intakes across studies. Hypocaloric LF diets use protein inefficiently, so more
dietary protein is needed to preserve lean body mass. Garrow and Summerbell (Garrow &
Summerbell, 1995) created a regression analysis from a meta-analysis predicting that 71% of a
10 kg weight loss obtained by dieting alone comes from fat-mass. This suggests dieting can
cause a 29% weight loss from tissue other than adipose. The more desired outcome is a result of
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a diet that can decrease fat mass but preserve lean body mass, which is seen in certain
circumstances when sufficient dietary protein is provided in a hypocaloric LCD (Krieger, Sitren,
Daniels, & Langkamp-Henken, 2006; J. S. Volek et al., 2002).
A comprehensive meta-analysis looked at 87 diet trials regarding dietary macronutrient
composition on body composition and concluded diets that restricted carbohydrates to some
degree resulted in greater fat loss. In addition, the meta-analysis found with weight loss, the
diets higher in protein percentage were associated with better preservation of lean body mass
(Krieger, et al., 2006). A recent systematic review (Hession, Rolland, Kulkarni, Wise, & Broom,
2009) concluded weight loss to be greater after 6 months and after 12 months on a VLCKD diet
compared to a LF diet. Additionally, at the same time points, the low-VLCKD diet significantly
improved subject cholesterol panels including triacylglycerols, and showed trends in
improvements of blood pressure and glucose. Interestingly, there were higher attrition rates of
those following the LF diet than those consuming the VLCKD.
Specifically looking at fat-mass loss, LCDs ensuing ketogenesis result in greater weight
loss and fat-mass loss than LF diets because the body does not catabolize protein if proper
ketoadaption occurs. In a study involving overweight men and women on a ketogenic LCD or a
LF diet, a 2-fold greater weight loss was observed in the LCD subjects despite similar caloric
restrictions (J. Volek et al., 2004; J. S. Volek, Fernandez, Feinman, & Phinney, 2008). In
normal weight men, LCDs significantly decreased fat-mass and significantly increased lean body
mass after 6 weeks of being in ketosis. Johnston (Johnston et al., 2006) compared weight loss
and other metabolic biomarkers in adults on a VLCKD and a LCD and found both groups
decreased body weight (6.3 kg and 7.2 kg, respectively) and fat mass (3.4 kg and 5.5 kg,

7

respectively) with no significant differences between groups. Body composition changes seem
favorable from a LCD in most all populations tested.
Severe energy restriction from hypocaloric diets can decrease nitrogen balance (Smith,
Underwood, & Clemmons, 1995), and small decreases in dietary protein could potentially
decrease lean body mass retention in the body. Therefore, ketogenic diets need to be well
formulated with sufficient protein to maintain or potentially increase nitrogen balance and thus
increase the amount of lean body mass retained. An early, well-controlled feeding study for 9
weeks improved body composition and nitrogen balance in men showing the effects of a well
formulated LCD. An 1800 calorie, intentional weight-loss diet with 115 grams of protein (25%
of energy) was sufficient for men to lose 12-18 kg of mostly fat mass, while maintaining
nitrogen balance (Young, Scanlan, Im, & Lutwak, 1971). An 8-week hypocaloric study in
women showed similar findings (Hoffer, Bistrian, Young, Blackburn, & Matthews, 1984).
Women who were fed 1.5g/kg protein, and supplemented with vitamins and minerals following a
LCD preserved more lean tissue mass than a cohort who consumed the same calories but only
0.8 g/kg protein. Results concluded the body is able to preserve lean tissue when adequate
protein and micronutrients are consumed, despite being in a major calorie deficit.

Modest body weight loss on a LCD may be explained by a loss of fat mass but a gain of
lean tissue. Research has shown it is possible to lose 100% of weight from fat mass on a
VLCKD and still gain lean body mass (J. S. Volek, et al., 2002). Twenty-four hour urine
collections with analysis of creatinine levels may help understand the gains of lean tissue seen in
some individuals who consume LCDs. Research has found a high positive correlation between
urinary creatinine concentrations and muscle mass (Edwards & Whyte, 1959), therefore, higher
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urinary creatinine levels in are typically seen with men more than women (Bjornsson, 1979;
Turner, 1975). Whole body muscle protein synthesis can be estimated from creatinine excretion
and can be compared to whole body protein synthesis calculated by leucine flux (Nair, Halliday,
& Griggs, 1988), a well-supplied nutrient on a LCD. Relating to resting energy expenditure
(REE), loss of lean body mass from energy deficient diets is correlated to decreases in REE
(Abraham & Wynn, 1987). However, when following a VLCKD or a LCD, REE has been seen
to significantly increase (Johnston, et al., 2006), perhaps explained by sufficient leucine intake
and lean tissue sparing, despite overall caloric deficit. Research has found resting metabolic
rates (RMR) to be 10% higher in individuals consuming a LCD than a LF diet (Blundell,
Cooling, & King, 2002) resulting in a considerable difference if calculated for calorie differences
over a month or year.

In a controlled, randomized 3-way crossover study design, overweight and obese adults
followed each different isocaloric macronutrient composition diet for a month. After achieving a
10-15% weight loss while consuming a ‘run-in’ diet, REE decreased the most following a month
of the LF diet (comprised of 60% carbohydrates, 40% fat, 20% protein) and decreased the least
with the VLCKD (comprised of 10% carbohydrate, 60% fat, 30% protein). Those on the LCD
expended 300 calories more a day than those on the LF and 150 more calories than on the lowglycemic diet (comprised of 40% carbohydrate, 40% fat, 20% protein) (Ebbeling et al., 2012).
These findings suggest the fewer carbohydrates consumed, the more energy expended by weightreduced individuals.
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Visceral adipose is highly active from a metabolic point of view. Visceral adiposity has
been shown an independent predictor of insulin sensitivity (Cnop et al., 2002), glucose tolerance
(Hayashi et al., 2003), elevated blood pressure (Bacha, Saad, Gungor, Janosky, & Arslanian,
2003) and dyslipidemia (Nieves et al., 2003). Research has found visceral adipose to be
associated with higher production of pro-inflammatory cytokines including tumor necrosis
factor-alpha (Bertin et al., 2000), plasminogen activator inhibitor-1 (Alessi et al., 1997),
interleukin-6, and C-reactive protein (You et al., 2008), all of which are associated with adverse
health effects. Visceral adiposity also leads to decreased secretion of growth hormone (GH),
even though insulin-like growth factor-1 (IGF-1) levels remain normal and GH-binding protein
levels are elevated (Maccario et al., 1999). Decreases in GH secretion have been associated
specifically with body fat distribution regarding abdominal obesity and increased visceral fat
(Johannsson et al., 1997).

In a cross-over, randomized study design comparing a LCD to a LF diet with similar
caloric restrictions, the LCD intervention resulted in twice the amount of fat-loss, of which most
was lost from the trunk region (J. Volek, et al., 2004). This study indicates that LCDs have the
potential to preferentially lose fat in a region that carries a large associated health risk. Therefore,
dietary interventions should focus on reducing visceral adiposity and decreasing the proinflammatory cytokines while maintaining lean body mass for maximal health benefits. In turn,
this would reduce the incidence of MetS and the growing obesity epidemic.

Body mass loss from LCDs can be variable and should be assessed using body
composition techniques allowing for discretion between lean body mass and fat mass, since a
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scale is not reflective of actual changes occurring in body tissues. A study involving individuals
with MetS used dual-energy x-ray absorptiometry (DEXA) analysis to compute body
composition and was able to identify a grander weight loss from LCD than a LF diet, with a 1.6fold greater fat loss specifically from abdominal adipose on the LCD (J. S. Volek et al., 2009).
Although results continuously report weight loss from the trunk region, the mechanisms of which
LCDs act upon body weight distribution in the mid-region are still unclear. A ‘metabolic
advantage’ may help explain some of the weight changes on a VLCKD. This metabolic
advantage may be explained by an increase in energy expenditure through the demand for
protein turnover through gluconeogenesis (Bisschop et al., 2000), a greater thermogenic effect
from protein and therefore a loss of energy as heat (Jequier, 2002), or simply excretion of
ketones in urine or feces while on a VLCKD.

Respiratory quotient (RQ) is consistently lower in people consuming a LCD in the fasting
and postprandial state than those consuming a LF diet (Blundell, et al., 2002). In the fasted state,
fat oxidation accounts for 53% of energy expenditure derived from fat oxidation in a LCD and
only 39% from a LF diet. An elevated RQ and lowered RMR are considered risk factors for
weight gain (Bouchard, 1996). Ketogenesis consumes oxygen but produces less carbon dioxide
often retaining or excreting ketones in the blood or urine, resulting in an RQ less than 0.7. A
lower RQ translates to increased oxidization of fat, increasing the flux of fat from adipocytes.
Research has shown that a higher 24-hour RQ, indicating low rates of fat oxidation relative to
carbohydrate oxidation, are associated with higher rates of subsequent weight gain (Zurlo et al.,
1990). Additionally, researchers have found higher RQ values to be associated with weight
fluctuations, ultimately leading to weight gain in subjects consuming a very low-calorie diet
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(Hainer et al., 2000). Therefore, conclusions suggest an elevated fasted RQ can be indicative of
weight gain through the impaired ability to burn fat (Valtuena, Salas-Salvado, & Lorda, 1997).

Insulin Sensitivity
LCD have been shown to consistently decrease circulating triglycerides (Westman, et al.,
2007) and stabilize blood glucose levels. Additionally, insulin secretion tends to be more
controlled. Therefore, carbohydrate restrictive diets should be used for lifestyle modifications in
diabetic individuals. With this in mind, assessing the homeostatic model of insulin resistance
(HOMA-IR) (Matthews et al., 1985), the most common measure of insulin resistance, or a newer
equation coined the insulin sensitivity index (ISI) (Venkataraman et al., 2013) would be useful in
identifying individuals with insulin resistance for risk of diabetes or future cardio-metabolic
events. The latter option takes into account triglycerides and waist-to-hip ratio, in addition to
fasting glucose and insulin levels, allowing for a more sensitive prediction equation in
calculating risk. Research shows following a VLCKD or a LCD for 6 weeks can significantly
improve insulin sensitivity (Johnston, et al., 2006). Another study compared obese non-diabetic
insulin sensitive women and obese non-diabetic insulin resistant women consuming hypocaloric
LF and LCDs for 16 weeks. Although the LCD was 40% carbohydrates, the insulin resistant
women lost significant more weight than those on the LF diet (13.4% vs. 8.5%, respectively).
This suggests insulin sensitivity is associated with the macronutrient composition of hypocaloric
diets (Cornier et al., 2005).
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Theoretical Low-Carbohydrate Ideas
Nonequilibrium Thermodynamics
A thermodynamic-based theory has previously been used to argue issues of weight
change stating ‘a calorie is a calorie’, but the basic ideas of nonequilibrium thermodynamics may
provide a more advanced explanation. The emphasis of nonequilibrium thermodynamics is
placed on the idea that systems may never attain equilibrium, and are constantly undergoing a
flux of material, typically through a catalyst or other factors that affect the rate of reactions.
Specifically with LCDs, adipocytes are continuously cycling between states of lipolysis or reesterification, depending on the hormonal state, which is controlled by dietary macronutrient
composition (Feinman & Fine, 2007). In other words, two calorically similar diets may affect
fat-mass differently because of their carbohydrate content and their affect on insulin levels.
Through glucose infusion testing, fat mobilization is decreased via the inhibition of lipolysis and
stimulation of re-esterification resulting in an increase of TAGs in the adipose (Wolfe & Peters,
1987). Authors predicted if a diet were to be fed over time with increasing carbohydrate levels,
the corresponding insulin levels would have a profound negative effect on lipase activity in
adipose tissue (Feinman & Fine, 2007). A LCD that did not affect insulin levels would reduce
lipogenesis and increase lipolysis, likely explaining some of the weight-loss accompanied with
the diet (Cahill, 2006; Veldhorst, Westerterp-Plantenga, & Westerterp, 2009). One downfall of
nonequilibrium thermodynamics is the inability for the equation to take into account de novo
fatty acid synthesis or hepatic production of β-hydroxybuterate, which has been shown to
increase twenty-fold while consuming a LCD. This level can blunt the effects of reduced insulin
concentrations (Taggart et al., 2005) by increasing insulin secretion. More research is needed to
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determine the effects of the innate compensatory processes involved with our complex biological
systems to fully understand the nonequilibrium thermodynamics theory.
Bluher and Kahn were some of the first to demonstrate the significant effects of
carbohydrate restriction on insulin stimulation of adipocytes. Using FIRKO mice (adipose
insulin receptor knockout mice), studies found animals consuming the same amount of food were
significantly thinner, had a reduced efficiency to store lipid and had increased longevity
compared to their wild type (Bluher, Kahn, & Kahn, 2003; Bluher et al., 2002). These mice are
potentially protected from obesity because of their lack of ability to be influenced by insulin.

Requirements of Metabolism
Substrate cycling refers to the dynamic process that must accompany the thermodynamic
steady state, constantly using ATP and generating heat to meet the metabolic demands of the
body. Similarly, the repeated breakdown and re-synthesis of proteins, lipids, and carbohydrates
use ATP with no apparent net gain. These processes allow for tight regulation of metabolism
and account for one of the many uses of ATP. More futile cycling of ATP occurs depending on
the pathway and initial substrate of which ATP is eventually produced. Glucose directly
oxidized to ATP is most efficient, where an average amino acid or protein oxidized to ATP is
largely inefficient. Utilizing lipids as the substrate to create ATP can be just as inefficient (Fine
& Feinman, 2004). In addition, the high costs of energy that occur with the formation and
hydrolysis of a single peptide bond in protein turnover can reduce metabolic efficiency
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(Waterlow, 1984). The variations in metabolic efficiency may help to explain the utilization of
ATP and energy expenditure, and argue the ideas of the first law of thermodynamics.

Gluconeogenesis-stimulated Protein Turnover
As glycogen stores are depleted while consuming a LCD, the requirements of glucose for
energy are met through gluconeogenesis. Since one still consumes minimal carbohydrates while
on a LCD (~20-50g), the brain needs to be supplied by the breakdown of protein or production of
ketone bodies. Through studies involving protein tracers, gluconeogenesis has been shown to
increased by day 11 on a LCD (Bisschop, et al., 2000). A sizeable amount of endogenous
protein needs to be broken down for gluconeogenesis and re-synthesized at an energy cost of up
to 400-600 kcals/day (Bisschop, et al., 2000). Gluconeogenesis can also be sourced by dietary
protein and is thought to conserve metabolic energy; however, the protein source to fuel
gluconeogenesis remains unclear (Bisschop, et al., 2000).

Behavioral Effects
Carbohydrate restrictive diets have been regarded a successful lifestyle change for
controlling body weight because they have been accredited with a behavioral effect (Feinman &
Fine, 2007). Several studies report when consuming an ad libitum LCD of 5-10% energy from
carbohydrates, people tend to consume less calories (Nordmann et al., 2006). In addition to a
behavioral effect, a metabolic effect or apparent reduction in energy efficiency has been seen in
isocaloric diet studies. This effect is often referred to as a metabolic advantage; people gain less
weight per calorie consumed (Feinman & Fine, 2007). One study using rats found those who
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consumed a LCD consumed less food and actually gained less weight per calorie consumed than
their counterparts who ate carbohydrates (Marsset-Baglieri et al., 2004). The metabolic
advantage can be reflected in a lower respiratory quotient without effecting resting energy
expenditure, metabolically expressed as an increased ability to efficiently oxidize TAGs as fuel
(Paoli et al., 2012). The thermogenic effect of burning proteins and fats through gluconeogenesis
may also affect the nonequilibrium equation favoring weight loss (Feinman & Fine, 2007; Fine
& Feinman, 2004).
The initial weight loss associated with a LCD is one of the most contended issues when
comparing LCDs to LF diets. Water is bonded with glycogen in muscle and adipose tissue in a
4:1 ratio. As glycogen stores deplete in the first days to weeks of a LCD, the initial weight loss
is mostly attributed to water loss mainly from the lean tissue. Research has found a 2 kg weight
loss to be associated with water and glycogen stores (Kreitzman, Coxon, & Szaz, 1992).
Similarly, after the ketogenic phase of a VLCKD when carbohydrates are cautiously added back
to the diet, one can expect a water weight gain as glycogen is being stored. This may help to
explain some of the weight changes over the course of a diet progression and justify the need to
analyze body composition via DEXA rather than a scale.
LCDs are often coupled with the absence of hunger (Weigle et al., 2005) and less energy
swings, as seen with people who consume carbohydrates regularly. There are a few theories
proposed to explain why those in a ketogenic state do not complain of the symptoms of
starvation: hunger, fatigue, or irritability like those who are purposefully avoiding calories for
weight loss reasons. Ketone bodies are thought to be partly responsible for the appetite
suppression (Johnstone, Horgan, Murison, Bremner, & Lobley, 2008). In addition, LCDs
promote consuming satiating fats and proteins that digest slower and keep one satiated longer
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(Westerterp-Plantenga, Nieuwenhuizen, Tome, Soenen, & Westerterp, 2009), and do not elevate
blood glucose, blood insulin levels or other appetite related hormones (Sumithran et al., 2013). In
a highly controlled study, subjects consuming a LCD reported hunger levels similar to those on a
LF diet, despite consuming 1000 kcals less each day (Boden, Sargrad, Homko, Mozzoli, & Stein,
2005).

Low-Carbohydrate Diet Research Limitations
A recent meta-analysis including 23 trials compared LCDs (defined as 4-45% of energy
from carbohydrate) with LF diets (defined as ≤30% energy from fat) on metabolic risk factors.
The main findings included an improved cholesterol panel with those in the LCD group, but no
significant differences between body weight and waist circumference (Hu et al., 2012). Perhaps
the wide range of carbohydrates in the LCDs grouped for analysis is the reason no differences
found for body composition measure, when typically the VLCKD or LCD shows improvements.
Ketogenesis does not occur unless carbohydrates are restricted to a more stringent degree, which
is necessary to liberate fatty acids from the adipose and utilize for energy.

Often LCDs are researched without an ample induction phase into ketosis. As mentioned,
carbohydrates need to be restricted for at least 3-4 weeks to see optimal benefits. Additionally,
individual subject’s starting lean body mass may dictate the degree to which lean body mass is
gained or lost. Although adipose tissue is 85% fat, overweight individuals, usually males,
require more muscle to carry the weight. When body weight is decreased, obligatory lean body
mass is lost since it is not required to carry a smaller load. In addition, there will always be
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people who respond to a diet intervention and those who do not, and these varied responses to
diet outcomes can likely be explained by genetics.

Understanding the theory of nonequilibrium thermodynamics may help to comprehend
the complexity of weight changes on diets that are similar in caloric content but different in
macronutrient composition. This idea really challenges the notion that ‘a calorie is a calorie’ in
respect to weight loss regimens and ultimately changing body composition. Hypocaloric, low-fat
diets are known to decrease body weight, typically comprising of weight from both fat mass and
lean body mass, but these results are undesirable for health outcomes. However, a diet able to
preserve lean body mass and efficiently decrease fat mass would be apt to decrease metabolic
syndrome in adults, thereby reducing risk for diabetes and cardiovascular events. Insulin plays a
significant role is regulating fat metabolism and specifically fat oxidation, primarily regulated by
carbohydrate level in the diet. Therefore, studying the role of carbohydrate content in a diet and
its’ effects on body composition may help elucidate a preferred diet for improved health
outcomes revolving around body weight. The primary aim of this study was to examine the
effects of dietary carbohydrate and fat manipulation in sequential diet phases of an isocaloric,
isonitrogenic, moderately calorie deficient controlled feeding study on body composition, fat
oxidation, respiratory quotient, and insulin changes.
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INTRODUCTION
Obesity is most accurately described as an excess storage of fat in adipose tissue.
Ultimately driving the storage of fat is the hormone insulin, which is under the influence of
carbohydrate consumption. Since storage of carbohydrate in the body is limited, carbohydrates
are metabolized to sugar and preferentially burned as fuel while simultaneously decreasing the
oxidation of fat for fuel. Carbohydrate intake above what can be stored or burned as fuel is
diverted to fat via de novo lipogenesis. With the increases in obesity rates and relatively high
rates of processed carbohydrates in the typical Western diet, understanding nutrient utilization
associated with dietary macronutrient compositions may help to understand the often dramatic
inter-individual differences in fat loss responses to diets varying macronutrient composition.
The oxidation of carbohydrates, proteins, and fats must occur in proportions matching the
composition of their nutrients in the diet, otherwise respective accumulation and/or depletion
occurs (Flatt, Ravussin, Acheson, & Jequier, 1985). Thus, in order to reduce fat mass a negative
state of fat balance must be achieved. A negative fat balance may be obtained by altering fat
intake or expenditure such that fat oxidation exceeds fat intake (Melanson, MacLean, & Hill,
2009), which has been shown to be most efficient while consuming a low-fat (LF) diet, also
resulting in increased energy expenditure (Hurni, Burnand, Pittet, & Jequier, 1982). These data
support the current American Dietary Guidelines (Services, December, 2010) to limit dietary fat,
but paradoxically the obesity epidemic has occurred during a time when dietary fat has been
replaced with an excess of carbohydrate among adults. Nutrient oxidation rates have been
shown to proportionally match dietary macronutrient composition percentages (Hurni, et al.,
1982) in subjects in weight maintenance when higher in carbohydrates for studies completing
24-hour analysis in a respiratory chamber. However, it remains unclear whether fat oxidation
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rates rise concomitantly with an increase in fat consumption (Schutz, Flatt, & Jequier, 1989)
indicating the potential for substantial imbalances between consumption and utilization when
dietary fat is substantial increased. When consuming an excess of carbohydrates, the body is able
to regulate carbohydrate oxidation after glycogen stores are saturated (Jequier & Schutz, 1983)
but how the body regulates dietary fat is less clear. One of the most cited studies compared
breakfasts of similar carbohydrate contents with altered fat compositions and found no increases
in postprandial fat oxidation (Flatt, et al., 1985), suggesting carbohydrate content of the diet is
influencing oxidation rates. The fact that dietary carbohydrate is a primary stimulator of insulin,
and insulin potently inhibits fat oxidation suggests that carbohydrate, or more specifically the
metabolic tolerance to carbohydrate, is a primary control element in determining fat balance.
While consuming a well formulated very low-carbohydrate diet (LCD), dietary fat intake is
greatly increased compared to current dietary guidelines (Lichtenstein, et al., 2006), and
presumably fat oxidation increases as well, but this has not been measured directly under
controlled conditions.
Despite much research performed on nutrient oxidation rates in exercise, very few studies
exist on nutrient oxidation rates in adults with metabolic syndrome (insulin resistance syndrome
or pre-diabetes). This population is known to have a disorder in glucose metabolism (i.e.,
carbohydrate intolerance) and generally impaired oxidative capacity of both glucose and fatty
acids (Westman, et al., 2007) potentially influencing insulin sensitivity at the skeletal muscle
cells (Horowitz, 2007) and exacerbating weight gain (Zurlo, et al., 1990).
It is increasingly recognized that individual variation is an important consideration in
interventions for weight loss and other health conditions, such as cardiovascular disease. Even in
highly controlled metabolic ward studies where dietary intake and exercise are tightly controlled,
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there is wide variability in weight loss and weight gain (Bouchard & Tremblay, 1997). Therefore,
different interventions may be better suited for specific individuals based on behavior and
biological factors, such as level of insulin resistance (McClain, Otten, Hekler, & Gardner, 2013;
J. S. Volek, et al., 2009) or genetic markers (J. Gardner et al., 2012; Qi et al., 2011; Seip et al.,
2008; Zhang, Wu, Liu, & Klaassen, 2012). Insulin resistance is known to vary across a spectrum
in individuals with metabolic syndrome, and this may manifest in variable fat loss to increasing
carbohydrate intake. For example, it has been shown that for individuals with insulin resistance,
a low carbohydrate diet dramatically outperforms a low fat diet as a weight loss intervention (C.
D. Gardner et al., 2007; J. S. Volek & Feinman, 2005; J. S. Volek, et al., 2009).
The unique feeding study design of 3-week continuous incremental increase in
carbohydrate and decrease in dietary fat from this study may help to shed light on the importance
of macronutrient distribution on substrate oxidation rates and fat mass changes in the context of a
moderate energy deficit. Using data obtained from indirect calorimetry (i.e., substrate oxidation
and respiratory exchange ratios) we will determine for the first time how incremental decreases
in fat and increases in carbohydrate affect substrate oxidation patterns and changes in body
composition within the same person while keeping caloric intake constant. A primary objective
of this research is to examine the role of varying carbohydrate and fat on the composition of
weight loss and the factors potentially modulating those effects. The specific aims of this study
were to: 1.) determine variability in fat loss velocity while consuming hypocaloric, isonitrogenic
diets that progressively alter the ratio of fat and carbohydrate in adults with metabolic syndrome
and 2.) examine the possible contribution of respiratory quotient (RQ), resting energy
expenditure, and insulin in explaining differences in fat loss over time. We hypothesized that
lower RQs or higher rates of fat oxidation would be associated with greater loss in body fat.
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Additionally, an increase in dietary fat consumption, and commensurate decrease in
carbohydrate, would increase whole body postabsorbtive fat oxidation rates. Since body weight
and body composition are complex traits influenced by a large number of metabolic
pathways/networks, we expect there will be wide variability between people in their response to
highly controlled diets varying carbohydrate and fat. It is also expected that a higher postabsorptive fat oxidation will show greater fat loss in the context of increasing dietary
carbohydrates. This may be related to the level of insulin resistance.
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METHODS
Screening
The University of Connecticut Institutional Review Board approved the study protocol.
Subjects were recruited through email list-serves, word of mouth, and posted flyers around the
local area. Subjects initially completed screening questionnaires for background information on
their medical, exercise and diet history and given written and oral details of the study
individually at a screening meeting. Women completed a menstrual history questionnaire
regarding information about hormonal supplements and symptoms of menopause to ensure no
confounding variables. Waist circumference and blood pressure were measured and a fasting
blood sample was obtained for determination of METs risk characteristics waist circumference >
35 in for women, >40 in for men; a systolic or diastolic blood pressure > 130/85 mmHg; a
fasting blood glucose >100 mg/dL; HDL-Cholesterol < 50 mg/dL for females, < 40 mg/dL for
males; triglycerides >150 mg/dL. Three of the five METs characteristics qualified a subject for
study enrollment. Sixty-three subjects were interested, attended a screening meeting, however,
only twenty-one subjects qualified and were enrolled. Exclusion criteria included individuals
who were lactose intolerant/ any food allergies, a medical history of Type 1 or Type 2 Diabetes
Mellitus, kidney, liver or any other metabolic or endocrine disorder, or currently using tobacco
products. Subjects needed to be between 21 and 70 years old and weight stable for the last 3
months, not taking any anti-inflammatory medications, not highly trained or currently
exceptionally active, not taking any other lipid or cholesterol medications, and either not taking
or on a stable medication for controlled blood pressure. Subjects agreed to follow the diet they
were given for the first three weeks and then only consume foods they were provided for the
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reminder of the study. Subjects agreed to not leave the state for extended periods of time during
the study protocol.
Study Design
week nutrition intervention consisting of 7 sequential 3-week
week phases. The
This was a 21-week
first three weeks of the study, described as a run
run-in “free-living phase”, 16 subjects consumed a
low-carbohydrate
carbohydrate diet. They were educated and instructed by a registered dietitian to consume
minimal carbohydrates and replace cal
calories with dietary fats. The following 6 phases (18 weeks)
all food was provided to subjects. Testing occurred before, and then after each phase as outlined
in Figure 1.

st
on a
Figure 1.. The study design schematic for sixteen subjects who started the study starting
low-carbohydrate diet.

Testing
Subjects arrived to the laboratory following a minimum 12
12-hour
hour fast and 24-hour
24
abstinence from exercise, caffeine, and alcohol. Testing included a 24
24-hour urine collection for
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urine nitrogen and ketone concentration prior to an indirect calorimetry test. On site, subjects
provided a small urine sample to assess specific gravity as a measure of hydration. Subjects with
a USG >1.025 were asked to consume water and wait 30 minute before another urine sample was
measured. Resting energy expenditure and substrate oxidation was measured by indirect
calorimetry (Parvomedics TrueOne 2400 metabolic cart) in a thermal neutral room. The
metabolic carts were calibrated with a standard gas mixture each morning. Subjects relaxed
quietly for approximately 30 min and oxygen consumption (VO2) and carbohydrate expiration
(VCO2) were averaged for 15 min to determine respiratory quotient (VCO2/VO2), relative rates
of carbohydrate and fat oxidation and metabolic rate (Weir, 1990). Body weight was measured
and recorded to the nearest 0.1 kg on a digital scale (OHAUS Corp., Parsippany, NJ) for each
subject. Height was recorded at the baseline via tape measurer and recorded to the nearest 0.1cm
and waist circumference was measured using a standard tape measurer performed by the same
person. Body composition was measured by dual-energy X-ray absorptiometry (DEXA)
(Prodigy, Lunar Corporation, Madison, WI) and analyzed by the same technician. All females
were given a pregnancy test (Quidel Corporation, San Diego, CA) through urine sample prior to
each DEXA scan.
Blood Draws and Analysis
Blood samples were obtained from an arm vein after subjects rested quietly for 15 min in
the supine position. Whole blood was collected into tubes with a serum separator and
ethylenediaminetetraacetic acid (EDTA). Tubes with serum separator remained at room
temperature for 15 min before spinning to allow clotting to occur. Whole blood was centrifuged
at 1500 x g for 15 min and 4ºC, aliquoted into storage tubes, and stored in ultra-low freezers for
batch analysis. Frozen samples were thawed only once before analysis. Serum glucose was
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determined by Quest Diagnostics (Wallingford, CT). Serum insulin was analyzed in duplicate
by ELISA (ALPCO, Salem NH) with a sensitivity of 5 mmol/L. Intra- and inter-assay
coefficients of variation (CV) were 5.3 and 7.2% respectively. Glucose and insulin values were
used to calculate an index of insulin resistance [HOMA-IR; calculated as Glucose
(mmol/L)·Insulin (µIU/mL /22.5)] (Matthews, et al., 1985). Total ketones were determined by a
cyclic enzymatic method that measures both acetoacetate (AcAc) and 3-hydroxybutyrate (3-HB)
(Wako Chemicals USA Inc, Richmond, VA) with a sensitivity of 1.2 µmol/L, and intra- and
inter-assay CV 7.7 and 20.3% respectively.
Dietary Intervention
Six diets were developed that spanned a range of carbohydrate from approximately 50 to
350 g/day (Feeding Phase 1→FP2→FP3→FP4→FP5→FP6) using nutrient analysis software
(Nutritionist Pro, Axxya Systems, Stafford, TX). The highest carbohydrate phase (FP6) was
designed to model national dietary recommendations. While carbohydrate was adjusted every 3
weeks, total fat decreased proportionately so that total energy remained constant. Saturated fat
was 40% of total fat for all phases. Protein was constant at 1.8 g/kg reference body weight
determined from midpoint of Metropolitan Height-Weight Tables. Based on individual resting
metabolic needs and activity factors (1.2-1.5) obtained at baseline, the diets were designed to
provide a 300 kcal/day energy deficit to induce moderate weight loss and motivation for subjects
to continue participation in the 21-week experiment. Thus, total caloric and protein intake for
each individual did not change throughout the study. Estimated nutrient composition of select
diets showed high concordance with chemical analysis (Exova, Portland, OR).
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For each diet phase 7-day rotational menus were developed that included a wide range of
whole foods. Beef, eggs, and dairy were used throughout all diet phases as primary sources of
saturated fat. For the low carbohydrate diet phases, higher-fat beef and meats, whole eggs, and
full-fat dairy products (e.g., cheese, whole milk yogurt, cream, butter) were emphasized. For the
higher carbohydrate diet phases with lower saturated fat, leaner versions of beef, egg substitutes,
and low-fat dairy (e.g., reduced-fat dairy, skim milk, low-fat/non-fat yogurt) were used instead.
Whole grain and relatively low glycemic index carbohydrate sources were emphasized.
Subjects were counseled to consume a 3-week run-in diet that mirrored the first feeding
phase. Thus, subjects consumed a diet similar to the lowest carbohydrate phase (Feeding Phase
1, ~50 g carbohydrate/day) in order to initiate metabolic adaptations to carbohydrate restriction.
Subjects complete three-day diet records at baseline to determine habitual nutrient intake and
during the run-in diet.

Food was prepared in our research kitchen, packaged and labeled per individual serving
sizes based on individual caloric and macronutrient needs and was picked up by the subjects 3-4
times/wk. All ingredients of meals were weighed to the nearest 0.1g on digital kitchen scales. If
unable to travel to obtain the food, arrangements were made to ensure the subject received
his/her food as planned. No other foods or beverages were allowed except very-low/non-caloric
products (e.g., coffee, tea, water, diet soda). All food containers were returned unwashed and
inspected to document that all food was consumed.
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Statistical Analyses
One subject dropped after completing FP4 due to a rise in his blood pressure. His FP5
and FP6 data were interpolated based on mean percent changes for the group. Unless otherwise
stated, a paired samples t-test was used to examine the effects of 6-week of very low
carbohydrate intake (BL verse FP1). Similarly, a repeated measures analysis of variance
(ANOVA) was used to assess changes across the six diet phases
(FP1→FP2→FP3→FP4→FP5→FP6) and Fisher’s LSD post hoc was used to examine pairwise
comparisons when significant main effects were observed. Correlations were done in multiple
variables using the Pearson’s r correlation coefficient with absolute numbers and/or change in
variable from the previous phase. Additionally, a multivariate linear regression analysis was
completed using the enter method. The alpha level for significance was set at p ≤ 0.05.
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RESULTS
Subjects
The descriptive characteristics of the 16 subjects are shown in Table 2. All but two
subjects qualified for this study with an increased waist circumference as a metabolic syndrome
characteristic. Twelve of sixteen subjects qualified with an elevated blood pressure (systolic or
diastolic >135/85 mmHg), nine subjects started with a low HDL (< 40 mg/dL for males, < 50
mg/dL for females), six subjects with a fasted triglyceride level >150 mg/dL, and ten subjects
with fasted blood glucose >100 mg/dL. All subjects qualified with at least 3 MetS
characteristics; five subjects qualified with four MetS characteristics, and two subjects started
with all five MetS characteristics.

Table 2. Baseline subject characteristics1.
Sex (M/F)
12/4
Age (yr)
44.9 ± 9.9
Body mass (kg)
108.4 ± 15.1
BMI (kg/m2)
37.9 ± 6.3
Waist Circumference (cm)
116.8 ± 10.5
Body Fat (%)2
40.0 ± 3.2
Total cholesterol (mg/dL)
191 ± 34
LDL-C (mg/dL)
123 ± 27
HDL-C (mg/dL)
42 ± 8
Triglycerides (mg/dL)
134 ± 54
Glucose (mg/dL)
100 ± 5
Insulin (pmol/L)
93 ± 70
Insulin Resistance (HOMA)3
3.3 ± 2.0
Ketones (mmol/L)
0.11 ± 0.06
Systolic Blood Pressure (mmHg)
122 ± 10
Diastolic Blood Pressure (mmHg)
83 ± 11
1Values are mean ± SD
2Determined by dual-energy X-ray absorptiometry
3HOMA = homeostatic model assessment = [fasting glucose (mmol/L) x insulin (mU/L)]/22.5
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Table 3. Average days subjects consumed each diet in the controlled feeding phases1.
Days in FL
1

LC-HC
30.4 ± 3.5
Values are mean ± SD

Days in
FP1
27.6 ± 3.9

Days in
FP2
27.8 ± 3.7

Days in
FP3
25.6 ± 3.8

Days in
FP4
24.3 ± 4.2

Days in
FP5
24.2 ± 2.6

Days in
FP6
21.8 ± 4.1

Dietary Intake
There were no significant differences in total days spent in each phase (Table 3). All
diets were well tolerated and compliance was high based on verbal communication and
inspection of returned, unwashed food containers. Total caloric intake at baseline showed an
average consumption of 2,969 kcal/day (Table 4). The controlled feeding diets averaged ~2,550
kcal/day. The diets provided were consistent with the goal to create a moderate calorie deficit
(~300 kcal/day) calculated from baseline REE and activity constant factor based on self-reported
activity. As designed, energy and protein intakes across the six controlled diet phases were
constant within each person. Habitual carbohydrate intake was 44% of total energy, slightly
lower than the average dietary recommendations. From FP1 to FP6, carbohydrate increased
from 47 to 346 g/day corresponding to 7% and 55% of total energy, respectively.
Fat consumption was 128 ± 45g (39%en) at baseline. Fat consumption increased to 152
± 46g in the FL phase, and was then controlled by researchers for FP1 through FP6 at 74%, 69%,
61%, 54%, 43%, and 28% total energy as grams of carbohydrate increased, respectively. Dietary
saturated fat was consumed at a constant 40% of fat calories across all phases. Protein was
provided at a consistent 1.8 g/kg reference body weight for each phase.
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Weight Loss, Resting Energy Expenditure
Relative to BL, cumulative mean weight loss after the free-living, FP1, FP2, FP3, FP4,
FP5 and FP6 phases was -3.7 ± 1.4, -6.4 ± 2.8, -7.9 ± 3.0, -8.4 ± 3.4, -8.5 ± 3.8, -9.4 ± 3.9, and 9.0 ± 4.5 kg, respectively. Relative to BL, cumulative body fat loss after FL through FP6 was 2.3 ± 1.5, -4.4 ± 2.1, -6.1 ± 3.1, -7.0 ± 3.3, -7.7 ± 3.5, -8.1 ± 4.1, and -8.3 ± 4.5 kg, respectively.
The variability in fat loss increased over time as carbohydrates were re-introduced, as evidenced
by the progressive increase in standard deviation from FP1 to FP6. Individual body fat mass loss
is represented as percent of body mass in Figure 2.

Individual Fat Mass Percent Change
Fat Mass Change (%)

0

-20

-40

BL

FL FP1 FP2 FP3 FP4 FP5 FP6

Phase
Figure 2. Individual change in fat mass percent over phases.
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For participant motivation, diets were designed in about a 300-calorie/day deficit
calculated from BL RMR analysis to promote a slight weight loss of about 0.3 kg/week or 1.0
kg/phase (about 0.6 lb/week or 1.8 lb/phase). After multiplying the actual calorie deficit
(calculated from REE delta change across phase, divided by two) multiplied by days in each
phase of the study, subject total caloric deficit can be translated into predicted fat mass deficit.
By this calculation, subjects were expected to lose -12.74 ± 15.81 kg in total over the 21-weeks.
Table 5 shows the average actual fat mass loss (kg) per phase and the predicted fat mass loss
(kg) per phase based on the calorie restriction. Actual fat mass loss was significantly different
after FL, but was not significantly less than predicted from FP2 through FP6 (Figure 3).

Fat Mass Change (kg)

Cumulative Predicted and
Actual Fat Mass Changes
Weeks

0
0

3

6

**

-4
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21

**** **** **** **** ****

Actual
Predicted

#

-8

#

-12

Figure 3. Cumulative predicted fat mass changes from controlled diet caloric deficit and actual
fat mass changes over weeks enrolled in the study, relative to baseline fat mass.1
1

Values are mean ± SE.
Significant change in body fat mass from FL via one-way ANOVA (p<0.01).
****
Significant change in body fat mass from FL via one-way ANOVA (p<0.0001).
#
Significantly less actual fat mass loss verse predicted fat mass loss via t-test (p<0.0001).
**
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Baseline resting energy expenditure (REE) was 2126 ± 276 kcals/day (Table 5).
Absolute REE was significantly lower at FP1 (1955 ± 270 kcals/day) than BL through a paired ttest (Figure 4), however the one-way ANOVA analysis comparing FP1 over the following six
phases found no significant differences. When expressed in relative terms (kcals/kg/day) to
account for body weight change over the hypocaloric diet feeding phases, REE did not
significantly change at any phase compared to BL (Figure 5).

Resting Energy Expenditure and
Body Weight Changes
Body Mass
REE
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Figure 4. Absolute resting energy expenditure and body weight changes across weeks in the
study. 1
1

Values are mean ± SE
Significant body mass change from BL via paired t-test (p < 0.0001).
**
Significant body mass change from FP1 via one-way ANOVA (p <0.0001).
#
Significant resting energy expenditure change from BL via paired t-test (p<0.01).
****
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Relative Resting Energy Expenditure
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Figure 5. Resting energy expenditure expressed as kcals/kg/day.1
1

Values are mean ± SE

Respiratory Quotient
Respiratory quotient (RQ) at baseline was 0.80 ± 0.05, which complements baseline
dietary records where subjects reported consuming a diet containing a moderate to high amount
of carbohydrates (44%en). RQ was significantly lower at FP1 when carbohydrate was lowest
and fat intake was the highest (0.75± 0.04) compared to BL via paired t-test. RQ increased
linearly as carbohydrates increased from FP1 through FP6: 0.75 ± 0.04, 0.77 ± 0.03, 0.79 ± 0.04,
0.80 ±0.04, 0.82 ± 0.03, 0.84 ±0.05, respectively (Figure 6). ANOVA comparisons result RQ
was significantly higher than FP1 at FP3 through FP6 (p<0.001). RQ was negatively correlated
to fat consumption (r= -0.303, p<0.001), and positively correlated to carbohydrate consumption
(r= 0.453, p<0.0001).
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RQ was significantly correlated to fat mass loss (r= 0.258, p<0.01) as shown in Figure 7.
Similarly, RQ was also correlated specifically to trunk fat loss (r= 0.224, p<0.005). The
relationship showed less fat mass loss with an increase in RQ.

Respiratory Quotient
Across Phases

0.9

RQ

**

**

**
**

*

0.8

0.7
BL

FL FP1 FP2 FP3 FP4 FP5 FP6

Phase

Figure 6. Respiratory quotient values for all subjects (n=16) measured after consumption of the
diet for about 3 weeks. 1
1

Values are mean ± SE
Significant change in RQ from baseline via paired t-test (p < 0.001).
**
Significant change in RQ from FP1 via one-way ANOVA (p< 0.001).
*
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Change in Fat Mass and RQ
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r = 0.258
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Figure 7. Correlation of the change in fat mass from the free-living phase through FP6 with
respective respiratory quotient.1
1

Correlation is significant (p<0.01)

Fasted Fat Oxidation
Fat oxidation rates were obtained by morning indirect calorimetry when subjects were
rested and fasted. At baseline, fat oxidation was 146 ± 37 g/day. With increases of dietary fat and
decreases of carbohydrate intake during the FL phase, fat oxidation significantly increased to 184
± 55 g/day (p< 0.01).
As carbohydrate was re-introduced from FP1 through FP6, fasted fat oxidation rates
steadily declined (173 ± 34, 165 ± 36, 150 ± 33, 136 ± 35, 127 ± 26, and 110 ± 33 g/day,
respectively). Fasted fat oxidation rates were significantly higher with the consumption of the
highest dietary fat (FP1: 173 ± 34 g/day), compared to dietary fat at BL (146 ± 37 g/day) (p<
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0.05), and significantly lower at the highest dietary carbohydrate phase (FP6: 110 ± 33 g/day),
compared to BL (p< 0.01) (Figure 8).
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Figure 8. Fasted fat oxidation and dietary fat consumption over weeks enrolled in the study.1
1

Values are mean ± SE
Significantly different fat oxidation compared to BL (p< 0.05).
**
Significantly different fat oxidation compared to BL (p< 0.01).
#
Significantly greater fat oxidation compared to fat consumption via t-test (p< 0.05).
*

Overall fasted fat oxidation was significantly correlated to fat consumption (r=0.438,
p<0.0001) when including baseline and free-living diets. When excluding these two phases that
were not controlled by the research team, fat oxidation and fat consumption were correlated to a
greater extent (r=0.629, p<0.0001). These results are shown in Figure 9. Similarly, fat oxidation
was negatively correlated to carbohydrate consumption (r= -0.397, p= <0.0001), and to a greater
extent when excluding BL and FL phases(r= -0.534, p= <0.0001) (Figure 10).
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Figure 9. Fasted fat oxidation correlation with fat consumption in all phases of the study (left)
and with just the controlled feeding phases (right) (p<0.0001).
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Figure 10. Fat oxidation correlation with carbohydrate consumption in all phases of the study
(left) and with just the controlled feeding phases (right) (p<0.0001).
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Insulin, Ketones, and HOMA
Serum ketones increased approximately 5-fold during FP1, 3-fold in FP2, and decreased
across phases until returning to baseline values by FP5. Ketones were significantly higher at FP1
from BL, and significantly lower at each phase from FP1 (Figure 11). Serum insulin and
HOMA (not shown) were significantly lower at FP1 than BL, and significantly higher at each
controlled feeding phase compared to FP1. Ketone levels were inversely correlated to trunk fat
mass change (r= -0.274, p<0.001), RQ (r= -0.419, p<0.0001), insulin levels (r= -0.319, p<0.001),
and carbohydrate consumption (r= -0.571, p<0.0001). Conversely, ketone levels were positively
correlated with fat consumption (r= 0.314, p<0.001).

Relative Serum Ketones and Insulin
40
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21
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-40
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Serum Insulin pmol/L

0.6

Ketones
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-0.2

Figure 11. Serum ketones and insulin expressed relative to baseline values.1, a
1

Values are mean ± SE
Insulin and ketones were both significantly higher at FP1 than BL via paired t-test. All following ketone
and insulin values were significantly different from FP1 via one-way ANOVA (p<0.0001).
a
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Dietary Correlations
Correlations of diet with body fat mass, trunk fat mass, and REE help explain some of the
change in rates of body fat loss. Table 6 is a correlation matrix of significant correlations
between dietary and metabolic variables analyzed as change from previous phase (FL-FP6)
and/or absolute numbers from the feeding phases (FP1-FP6 only). Through regression analysis,
37% of fat mass loss could be predicted by absolute RQ, fat consumption, carbohydrate
consumption, insulin, ketones, and fat oxidation.

40

DISCUSSION
Dietary guidelines currently recommend low-fat diets to be the most ideal for weight loss,
suggesting the difference between fat intake and oxidation is ideal for being in a negative fat
balance. Nevertheless, obesity rates have continued to rise over the past few decades. In this
study, we sought to shed light on the individual variability of changes in weight loss, respiratory
quotient, resting energy expenditure, and fat oxidation when consuming different controlled
hypocaloric diets, varying in fat and carbohydrate content. Subjects were studied over 21 weeks
while consuming diets that were progressively higher in carbohydrates and lower in dietary fat in
a dose-response manner. The results show consistent body mass and fat mass loss while
consuming a low-carbohydrate diet and a lower rate of fat mass loss while consuming a highcarbohydrate diet. Actual fat loss was less than predicted fat loss in each phase, with wide
variation within subjects reflected by a large standard deviation (and range). Additionally, the
lowest RQ and highest fat oxidation rates with diets containing the most dietary fat and least
amount of carbohydrates. As dietary carbohydrates increased, RQ increased and fat oxidation
decreased. Our results suggest dietary carbohydrates influence RQ, insulin levels, and fat
oxidation, slow the rate of weight loss. Therefore, quantitative information on carbohydrate
consumption can be useful with making predictions of weight change and assist with making
weight management recommendations to adults with metabolic syndrome.
Variability in fat loss in response to increasing carbohydrate intake in the context of
moderately hypocaloric feeding was remarkable. Based on calculations of predicted fat mass
deficit from the energy restricted diets and change in RMR, subjects should have lost 15 kg of fat
mass while in the six controlled feeding phases, however actual fat loss was 6.0 kg (range: 1.0–
13.9 kg), with a total of 8.34 kg including the run-in free living phase. Weight loss, specifically
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fat mass loss and trunk fat loss, occurred to a greater extent while consuming the lowcarbohydrate/high fat diet and slowly tapered to a minimal loss while consuming a high
carbohydrate diet. Perhaps the most intriguing finding is the variation in weight change at each
phase. This finding suggests it is difficult to estimate how much weight any individual may lose
even with a constant caloric deficit since dietary macronutrient composition clearly regulates
metabolism. The variation in weight change is highly correlated to the presence of insulin,
elevated in the presence of dietary carbohydrates, while simultaneously decreasing fasted fat
oxidation (Table 6), promoting the storage of excess carbohydrates.
Actual fat mass loss at FL was statistically different from predicted fat loss; however,
there were no significant differences between actual and predicted fat mass loss during the
feeding phases. It may be assumed the weight loss in the early phases likely occurred from the
caloric deficit, however, within the same caloric restriction confinements, by FP6 there was a
range of -3 to -41% cumulative fat mass loss within adults with metabolic syndrome. Our study
found a weight-loss induced non-significant decrease in absolute REE across phases, where in
FP6 the REE was significantly lower than baseline. The maintained relative REE (kcals/kg/day)
rationalizes the unnecessary need to reassess provided calories as subjects lost weight, indicating
metabolism did not slow as subjects lost weight, similar to previous findings (J. Volek, et al.,
2004).
In regards to REE, it has been previously shown that the body has the ability to maintain
REE when following a low-carbohydrate diet (J. Volek, et al., 2004). Researchers believe
consuming the low-carbohydrate diet first did not provide an order effect. Similar results of
weight changes have been observed in obese subjects participating in a crossover study
consuming hypocaloric macronutrient-different diets (Rabast, Vornberger, & Ehl, 1981),
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implying less fat mass loss while consuming a high carbohydrate diet would have occurred even
if the diets were to have been reversed. Additionally, if the caloric deficit is able to explain the
initial weight loss, feeding the diets in reverse order (high carbohydrate to low-carbohydrate)
may have maintained the rate of fat mass loss through a lower RQ as carbohydrate consumption
decreases. This addresses the on going debate as to the ideal initiation of a low-carbohydrate
diet: eliminate all dietary carbohydrate sources to rapidly deplete glycogen stores and initiate
high efficiency fat-oxidizing capacity, or gradually reduce dietary carbohydrates allowing
equilibration of nutrient oxidation at incremental decreases. Research specifically aimed at this
question in terms of weight loss, substrate oxidation, and RQ has yet to be published.
Respiratory quotient tracked consistently with the pattern of progressively increasing
carbohydrates across phases. Despite variability between subjects, RQ was significantly
different from baseline (0.80) values at the lowest carbohydrate-feeding phase (0.75) where
subjects had the greatest rate of weight loss. Not surprisingly, RQ significantly increased as
dietary carbohydrate percentage increased. Researchers suspect if RQ were to have been
monitored in a respiratory chamber over 24 hours, the postprandial RQ in FP5 and FP6 would
have exceeded 1.0 in some subjects, indicating elevated carbohydrate oxidation and de novo
lipogeneis (Acheson et al., 1988). Our study found increases in RQ to be correlated with
carbohydrate intake (r2= 0.20, p=<0.0001), and with a decreased rate of weight loss (r2= 0.24,
p=<0.0001), consistent with previous findings correlating higher RQs to weight gain and weight
fluctuations (Hainer, et al., 2000; Valtuena, et al., 1997; Zurlo, et al., 1990). Despite our results
demonstrating RQ predicting only 8% of fat mass change, other metabolic variables (insulin,
ketones, fat oxidation) and dietary components (fat and carbohydrate consumption) correlate
highly with each other. Therefore, theoretically an individual may be able to use a fasted RQ as
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a function of current fat and carbohydrate intake to predict subsequent weight change while
consuming diets of different macronutrient proportions. Moreover, an individual who can
maintain a lower RQ (meaning a higher fat to carbohydrate oxidation ratio) with increasing
consumption of carbohydrates may possess an enhanced ability for weight maintenance and/or
weight loss.
Increases in carbohydrate oxidation have been previously shown to increase parallel to
intake levels (Acheson, Flatt, & Jequier, 1982; Acheson, Thelin, Ravussin, Arnaud, & Jequier,
1985), demonstrating the flexible capacity of the body to use carbohydrates for energy. When
consumed in excess (above storage capacity as glycogen), de novo lipogenesis occurs, resulting
in adipose mass gains with simultaneous decreases in fat oxidation or increases in carbohydrate
oxidation (Acheson, et al., 1988). It has been proposed that adiposity expansion also occurs with
high fat diets because oxidation rates have not been shown to match the increases (Westerterp,
1993). The current results provide intriguing data showing fasted and resting fat oxidation rates
can increase in the absence of carbohydrates (7%en), ultimately demonstrating carbohydrates to
be regulating nutrient metabolism. We found fat consumption to predict 40% of fat oxidation and
carbohydrate consumption to predict 29% of fat oxidation (Figure 9, Figure 10) suggesting
other dietary or metabolic variables account for only a small percentage of fat metabolism.
Additionally, fasted fat oxidation linearly decreased as dietary carbohydrate content
incrementally increased. Fat oxidation rates were significantly lower than baseline when
consuming 346 g/day of carbohydrates (FP6), even after subjects had experienced significant
weight loss. This finding was interesting and unexpected, as we would have expected
improvement in the ability to oxidize glucose and fatty acids in adults with metabolic syndrome
as they became less obese (Westman, et al., 2007) and were consuming a similar amount of

44

carbohydrates prior to starting the study. Subjects may have reached their ‘threshold’ of
carbohydrate tolerance in FP6 where the body can no longer utilize or oxidize what was
consumed. This suggests de novo lipogenesis was occurring at FP6 and may further explain the
decline in weight loss.
In terms of protein oxidation, we assume net protein balance in this study secondary to
the ability of the body to preserve lean body mass when consuming sufficient dietary protein
with a hypocaloric diet (Krieger, et al., 2006; J. S. Volek, et al., 2002). In this case, we
purposefully designed the diets to contain 1.8 g protein per kg reference body weight across all
controlled feeding phases to lessen the likelihood of adverse loss of lean body mass in the
presence of body weight loss. Our results found fat mass to account for 93% of total body
weight loss over the 21 weeks when consuming protein at this adequate level.
The relatively short feeding phases of the study can be considered a design limitation.
These were intended to keep menus changing and subjects interested in continuing the study.
Subjects reported feeling full, satisfied, and able to maintain energy levels throughout the day
while consuming the small volume, calorically dense low-carbohydrate diets, despite being in a
moderate hypocaloric state. However, while consuming the high-carbohydrate diets, that were
much greater in food volume and were not as calorically dense in weight, subjects complained of
bloating, tiredness, and intermittent hunger. Paradoxically, the highest carbohydrate diet
consisted of 55%en carbohydrates, which may not fully represent the high carbohydrate diets
consumed by adults with metabolic syndrome. Furthermore, oxidation rates were taken
following an overnight fast, therefore, do not account for daily activity or postprandial changes.
Otherwise, this unique 18-week feeding study with an additional 3-week run-in diet is the first to
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analyze adults with metabolic syndrome over a series of controlled hypocaloric diets, ranging
from 7-55% carbohydrates, using DEXA, indirect calorimetry and related blood marker analysis.
In summary, in the context of a low-carbohydrate diet, high intakes of dietary fat
(including 40% saturated fats) can still promote substantial weight loss (and fat mass loss),
greater than a low-fat diet indicating that fat oxidation is particularly responsive to dietary
carbohydrate. Specifically, this study has shown the ability of the body to preferentially lose
trunk fat mass while maintaining lean body mass under weight loss conditions. Although we
report significant correlations between elevated respiratory quotient, insulin, and carbohydrate
consumption with the decreased ability to lose weight, there remains a large unexplained
variability. These results are consistent with the notion that individuals vary in their tolerance to
carbohydrate and therefore may need to personalize their intake of carbohydrate in order to
promote continued fat loss. Monitoring of metabolic parameters may be useful to determine
individual responses to graduated increases in carbohydrate.
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Table 4. Daily nutrient intakes at baseline (habitual diet) and during each dietary phase1.
Controlled Feeding Phases
Baseline2
Energy (kcal)
Protein (g)
Carbohydrate (g)
Fat (g)
SFA (g)
MUFA (g)
PUFA (g)
Cholesterol (mg)
Fiber (g)
1
2

FP1

2969 ± 1058 2553 ± 327
130 ± 45
129 ± 7
324 ± 150
47 ± 2
128 ± 45
209 ± 34
45 ± 19
84 ± 14
33 ± 13
77 ± 14
20 ± 10
31 ± 5
534 ± 225
844 ± 96
26 ± 15
15 ± 1

FP2
2527 ± 339
125 ± 6
83 ± 4
193 ± 35
76 ± 15
64 ± 11
35 ± 8
878 ± 91
19 ± 1

FP3
2585 ± 286
125 ± 8
131 ± 3
179 ± 29
71 ± 11
57 ± 8
35 ± 9
824 ± 68
23 ± 4

Values are mean ± SD from all 16 subjects.
Determined from 3-day diet records
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FP4

FP5

FP6

2506 ± 332
123 ± 9
179 ± 2
152 ± 34
61 ± 15
48 ± 11
27 ± 7
583 ± 131
27 ± 3

2517 ± 339
123 ± 10
251 ± 12
121 ± 32
49 ± 14
36 ± 10
24 ± 6
448 ± 136
29 ± 2

2509 ± 336
123 ± 11
346 ± 28
80 ± 27
32 ± 11
24 ± 8
14 ± 5
334 ± 154
35 ± 5

Table 5. Actual and predicted fat mass loss per feeding phase. 1
LowCarbohydrate
Free-Living

FP1

FP2

FP3

FP4

FP5

FP6

REE2
(kcals/day)

2113 ± 387

1995 ± 270

1986 ± 277

1967 ± 306

1967 ± 301

1970 ± 268

1908 ± 303

Calorie Deficit
(kcals/phase)3

20998 ± 19135

5737 ± 9222

4046 ± 7589

3676 ± 6039

3648 ± 4268

3811 ± 4239

2661 ± 4818

Predicted FM
Loss (kg)

-6.00 ± 5.47

-1.64 ± 2.63

-1.16 ± 2.17

-1.05 ± 1.73

-1.04 ± 1.22

-1.09 ± 1.21

-0.76 ± 1.38

Actual FM
Loss (kg)

-2.32 ± 1.53 a

-2.10 ± 1.52

-1.63 ± 1.41

-0.97 ± 0.77

-0.65 ± 1.01

-0.40 ± 1.12

-0.27 ± 1.48

1

Values are mean ± SD from all 16 subjects.
Resting energy expenditure
3
Calculated by: Calorie deficit= calories consumed – (REE, determined by change in needs each day through calculation of change between
phases, divided by days in each phase) * IPAQ activity factor * average days in each phase (Table 3).
a
Actual fat mass loss is significantly less than predicted fat mass loss (p<0.0001)
2
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Table 6. Selected additional correlations between dietary and metabolic variables.
Change1 in Body Mass

Change1 in Fat Mass

Change1 in Trunk Fat Mass
Change1 in Fat Oxidation
Absolute2 Trunk Fat Mass
Absolute2 Fat Mass
Absolute2 Body Mass
Absolute2 Ketones
Absolute2 Carbohydrate Consumption
1
2

Correlation Variable
Change in Insulin
Change in Ketones
Change in Carbohydrate Consumption
Change in Fat Consumption
Change in Ketones
Change in Carbohydrate Consumption
Change in Fat Consumption
Change in Carbohydrate Consumption
Change in RQ
Absolute Insulin
Absolute Insulin
Absolute REE
Absolute RQ
Absolute Fat Consumption
Absolute RQ
Absolute Ketones

Change from previous phase (FL-FP6)
Absolute is actual number from feeding phases (FP1-FP6)
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Pearson's r
0.34
-0.46
0.49
-0.49
-0.32
0.42
-0.38
0.33
-0.87
0.51
0.53
0.63
-0.42
-0.57
0.45
-0.51

n size
112
112
112
112
112
112
112
112
112
96
96
96
96
96
96
96

r2
0.116
0.212
0.240
0.240
0.102
0.176
0.144
0.109
0.757
0.260
0.281
0.397
0.176
0.325
0.203
0.260

P-value
<0.001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.0001
0.001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
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